Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 839,980
  • Shares Outstanding, K 88,326
  • Annual Sales, $ 23,960 K
  • Annual Income, $ -36,250 K
  • 60-Month Beta 2.65
  • Price/Sales 23.36
  • Price/Cash Flow N/A
  • Price/Book 15.23
Trade AFMD with:

Options Overview

Details
  • Implied Volatility 86.81%
  • Historical Volatility 99.02%
  • IV Percentile 3%
  • IV Rank 3.36%
  • IV High 491.38% on 04/28/20
  • IV Low 72.75% on 05/15/20
  • Put/Call Vol Ratio 0.97
  • Today's Volume 1,993
  • Volume Avg (30-Day) 2,730
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 33,696
  • Open Int (30-Day) 16,381

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.14 +33.19%
on 03/30/21
10.79 -11.86%
on 04/14/21
+1.17 (+14.03%)
since 03/16/21
3-Month
4.78 +98.95%
on 03/05/21
10.79 -11.86%
on 04/14/21
+2.63 (+38.23%)
since 01/15/21
52-Week
1.88 +405.85%
on 05/14/20
10.79 -11.86%
on 04/14/21
+7.35 (+340.28%)
since 04/16/20

Most Recent Stories

More News
XOMA's Royalty Portfolio Grows with Addition of Three Royalty Assets

XOMA Corporation (Nasdaq: XOMA) today announced its portfolio of potential future milestone and royalty assets has increased with the addition of three Affimed N.V. (Nasdaq: AFMD) innate cell engager (ICE)...

XOMA : 37.50 (-0.92%)
AFMD : 9.51 (+0.32%)
Affimed NV to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 15, 2021 / Affimed NV (NASDAQ:AFMD) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on April 15, 2021 at 8:30 AM Eastern...

AFMD : 9.51 (+0.32%)
Company News for Apr 12, 2021

Companies in the news are: AFMD, FUBO, GENE, CELC

AFMD : 9.51 (+0.32%)
GENE : 3.87 (-0.77%)
CELC : 25.88 (-2.52%)
FUBO : 18.86 (-2.23%)
Thinking about buying stock in Affimed NV, Geovax Labs, TherapeuticsMD, Fortress Biotech, or Fubotv?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AFMD, GOVX, TXMD, FBIO, and FUBO.

AFMD : 9.51 (+0.32%)
GOVX : 4.77 (-0.83%)
TXMD : 1.1850 (-2.07%)
FBIO : 4.12 (-7.21%)
FUBO : 18.86 (-2.23%)
Affimed (AFMD) Catches Eye: Stock Jumps 8.8%

Affimed (AFMD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

AFMD : 9.51 (+0.32%)
RCUS : 33.13 (-5.32%)
Thinking about buying stock in Affimed NV, Kura Oncology, Matinas BioPharma, Uranium Energy, or Senseonics Holdings?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AFMD, KURA, MTNB, UEC, and SENS.

MTNB : 0.9006 (+1.19%)
SENS : 1.8900 (-4.55%)
UEC : 2.75 (-2.14%)
AFMD : 9.51 (+0.32%)
KURA : 28.59 (-2.99%)
Affimed N.V. (AFMD) Reports Q3 Loss, Tops Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of 33.33% and 94.55%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

AFMD : 9.51 (+0.32%)
Affimed N.V.: 3Q Earnings Snapshot

HEIDELBERG, Germany (AP) _ Affimed N.V. (AFMD) on Tuesday reported a loss of $7 million in its third quarter.

AFMD : 9.51 (+0.32%)
Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

-- Pre-clinical data substantiates synergy between Affimed's ICE molecules and both NKMax America's autologous and cryopreserved allogeneic NK cell therapy products

AFMD : 9.51 (+0.32%)
Affimed N.V. (AFMD) Reports Q2 Loss, Lags Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of -50.00% and -52.45%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

AFMD : 9.51 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V.,...

See More

Key Turning Points

3rd Resistance Point 10.14
2nd Resistance Point 9.87
1st Resistance Point 9.69
Last Price 9.51
1st Support Level 9.24
2nd Support Level 8.97
3rd Support Level 8.79

See More

52-Week High 10.79
Last Price 9.51
Fibonacci 61.8% 7.39
Fibonacci 50% 6.33
Fibonacci 38.2% 5.28
52-Week Low 1.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar